BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IGF1
,
glucose metabolic process
,
Diabetes mellitus
,
Neuron
,
Neocentromeres
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
xiap protein human
Summary
General Info
Curated Studies
Most Correlated Studies
XIAP knockdown in HCT116 colon cancer cells
Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
Acute myeloid leukemia resistance to inhibitor of apoptosis protein antagonist BV6
Non-Hodgkin lymphoma Mino cells treated with ARV-771, ARV-825 or OTX015
Acute myelocytic leukemia ML-2 cells treated with SGI-110 alone or in combination with ASTX660
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key P…
Maternal Gonosomal Mosaicism Causes XIAP Deficiency.
Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Computational Tool to Design Small Synthetic Inhibitors Selective for XIAP-BIR3 Domain.
Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors an…
Study of Vorinostat (MK-0683) an HDAC Inhibitor, or Placebo in Combination With Bortezomib in Patien…
Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ